These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 24502949

  • 1. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.
    Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M.
    Cancer Res; 2013 Jan 01; 73(1):406-16. PubMed ID: 23135908
    [Abstract] [Full Text] [Related]

  • 3. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.
    Stem Cells; 2010 Jan 01; 28(1):5-16. PubMed ID: 19904829
    [Abstract] [Full Text] [Related]

  • 4. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.
    Barat S, Chen X, Cuong Bui K, Bozko P, Götze J, Christgen M, Krech T, Malek NP, Plentz RR.
    Stem Cells Transl Med; 2017 Mar 01; 6(3):819-829. PubMed ID: 28186678
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M, Xie J, Li T, Hou Y, Wu D.
    J Cell Biochem; 2014 Jun 01; 115(6):1112-21. PubMed ID: 24356998
    [Abstract] [Full Text] [Related]

  • 7. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC, Hung SC, Chen YC, Tseng LM, Chiou SH.
    Cancer; 2011 Jul 01; 117(13):2970-85. PubMed ID: 21225866
    [Abstract] [Full Text] [Related]

  • 8. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G, Deng S, Guo W, Yu L, Yang J, Zhou S, Gao T.
    Mol Carcinog; 2019 Jan 01; 58(1):3-18. PubMed ID: 29964327
    [Abstract] [Full Text] [Related]

  • 9. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, Dang TP.
    Cancer Res; 2007 Sep 01; 67(17):8051-7. PubMed ID: 17804716
    [Abstract] [Full Text] [Related]

  • 10. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R, Wang G, Song Y, Tang Q, You Q, Liu Z, Chen Y, Zhang Q, Li J, Muhammand S, Wang X.
    Mol Med Rep; 2015 Aug 01; 12(2):2417-24. PubMed ID: 25936357
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3.
    Hemati H, Kaur J, Sobti RC, Trehanpati N.
    Biochem Biophys Res Commun; 2020 May 14; 525(4):941-947. PubMed ID: 32173531
    [Abstract] [Full Text] [Related]

  • 13. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W, Gao Z, Duan Y, Yuan W, Ke Y.
    J Exp Clin Cancer Res; 2017 Mar 09; 36(1):41. PubMed ID: 28279221
    [Abstract] [Full Text] [Related]

  • 14. Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+ endometrial cancer cells.
    Shang C, Lang B, Meng LR.
    Cancer Biol Ther; 2018 Feb 01; 19(2):113-119. PubMed ID: 27791463
    [Abstract] [Full Text] [Related]

  • 15. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
    Wang M, Ma X, Wang J, Wang L, Wang Y.
    Int J Oncol; 2014 Apr 01; 44(4):1401-9. PubMed ID: 24535252
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling.
    Yu L, Fan Z, Fang S, Yang J, Gao T, Simões BM, Eyre R, Guo W, Clarke RB.
    Oncotarget; 2016 May 31; 7(22):33055-68. PubMed ID: 27102300
    [Abstract] [Full Text] [Related]

  • 18. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M, Osipo C.
    Cells; 2020 Sep 29; 9(10):. PubMed ID: 33003540
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. γ-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.
    Lin J, Zhang XM, Yang JC, Ye YB, Luo SQ.
    Arch Med Res; 2010 Oct 29; 41(7):519-29. PubMed ID: 21167391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.